Meet NP, an 18-year-old male who came in for his annual eye exam shortly after starting Accutane, a medication known to reduce oil production and commonly used to treat severe acne. However, Accutane can also impact the oil glands in the eyelids, putting patients at risk for dry eye and potential meibomian gland dysfunction (MGD).
🧐 Key Findings:
- Diagnosis: Meibomian gland dysfunction (MGD) developing secondary to Accutane use.
- Accutane Details: Accutane (Isotretinoin) is a powerful retinoid that can reduce sebum production in skin and oil production in eyelid glands, leading to potential dryness and gland damage.
- Contraindications: NP could not receive Intense Pulsed Light (IPL) therapy, as Accutane can cause photosensitivity.
- Clinical Exam: Meibography scans taken before Accutane showed healthy meibomian glands. However, early follow-ups revealed notable structural changes as a result of Accutane.
Treatment Plan:
To prevent long-term gland loss, we opted for LipiFlow, a thermal treatment that unclogs and maintains meibomian gland function without photosensitivity risks. Thanks to early intervention, we successfully maintained NP’s gland health and avoided irreversible damage.
Outcome:
After NP’s Accutane treatment ended, his meibomian glands returned to normal structure, ensuring long-term eye comfort and healthy gland function.
Conclusion:
Even young patients can face serious dry eye risks, especially when taking systemic medications like Accutane. Early intervention and careful monitoring can make all the difference in protecting long-term ocular health.